Blake Anson

Blake Anson has a diverse work experience in the biopharmaceutical industry spanning over several years. Blake currently holds the position of Senior Director - Discovery Research Partnering at FUJIFILM Cellular Dynamics since July 2023. Prior to that, they worked as a Business Development Advisor at Candidate Biopharma Advisors starting from March 2023.

From June 2022 to March 2023, Blake served as the Vice President of Business Development at AnaBios Corporation. In this role, they were responsible for managing the toxicity service portfolio and cardiac services across multiple markets. Blake worked collaboratively with various stakeholders to align marketing efforts and product development.

Before joining AnaBios Corporation, Blake held the position of Vice President, Scientific Affairs and Partnering at Vyant Bio from April 2021 to May 2022. Blake led scientific outreach, corporate awareness, and partnering efforts while overseeing sales and marketing activities in the early discovery and toxicity testing field. Blake also played a key role in conducting scientific and operational due diligence as part of an acquisition team.

Blake's work experience also includes roles at StemoniX, where they served as the Vice President of Business Development from March 2020 to May 2021 and as the Senior Director of Marketing and Strategic Alliances from January 2019 to March 2020. At StemoniX, they focused on driving business development and establishing strategic partnerships.

In their early career, Blake worked at Cellular Dynamics International for several years in various roles. From September 2016 to December 2018, they served as the Global Business Director/Director Strategic Alliances, leading new strategic business unit teams. Blake played a crucial role in forming public and private alliances in alignment with division strategy. Prior to that, Blake held the position of Product Manager/Senior Product Manager, where they led the commercial development and launch of the first industrialized human induced pluripotent stem cell (iPSC) cardiomyocyte product. Blake also served as the Director of hERG Screening Services, where they established a GLP-compliant screening service.

Overall, Blake Anson has demonstrated expertise in business development, strategic partnerships, and scientific affairs throughout their career in the biopharmaceutical industry.

Blake Anson holds a Bachelor of Science degree in Zoology from the University of Wisconsin-Madison. Additionally, they have obtained a Ph.D. in Neuroscience from the University of Oregon.